New substituted 9-alkylpurines as adenosine receptor ligands

Bioorganic and Medicinal Chemistry

Volumn 6, Issue 5, 1998, Pages 523-533

  Camaioni, Emidio ^a   Costanzi, Stefano ^a   Vittori, Sauro ^a   Volpini, Rosaria ^a   Klotz, Karl Norbert ^b   Cristalli, Gloria ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenosine antagonists; Adenosine receptors; Purine derivatives

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 ETHYLPURINE DERIVATIVE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR AFFECTING AGENT; ADENYLATE CYCLASE; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; ALKYLATION; ANIMALS; CHO CELLS; CRICETINAE; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; PURINES; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031776418     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(98)00007-8     Document Type: Article

References (30)

1. Müller, C. E.; Scior, T. Pharm. Acta Helv. 1993, 68, 77.
2. (a) Daly, J. W.; Jacobson, K. A. In Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology; Belardinelli, L.; Pelleg, A., Eds.; Kluwer Academic: Boston, 1995; p 157.
3. (b) Fredholm, B.; Abbracchio, M. P.; Burnstock, G.; Daly, J. W.; Harden, T. K.; Jacobson, K. A. Leff, P.; Williams, M. Pharmacol. Rev. 1994, 46, 143.
4. Daly, J. W.; Butts-Lamb, P.; Padgett, W. Cell. Mol. Neurobiol. 1983, 3, 67.
5. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. J. Med. Chem. 1992, 35, 407.
6. Belardinelli, L.; Shryock, J. C.; Zhang, Y.; Scammells, P. J.; Olsson, R.; Dennis, D.; Milner, P.; Pfister, J.; Baker, S. P. J. Pharmacol. Exp. Ther. 1995, 275, 1167.
7. Lohse, M. J.; Klotz, K-N.; Lindenborn-Fotinos J.; Reddington M.; Schwabe U.; Olsson R. A. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 336, 204.
8. (a) Siddiqi, S. M.; Ji, X. D.; Olah, M. E.; Melman, N.; Olah, M. E.; Jain, R.; Evans, P.; Glashofer, M.; Padgett, W. L.; Cohen, L. A.; Daly, J. W.; Bellamkonda, Y.; Stiles, G. L.; Jacobson, K. A. Nucleosides Nucleotides 1996, 15, 693.
9. (b) Baraldi, P. G.; Cacciari, B.; Spalluto, G.; Borioni, A.; Viziano, M.; Dionisotti, S.; Ongini, E. Curr. Med. Chem. 1995, 2, 707.
10. (a) Ongini, E.; Fredholm, B. B. TiPS 1996, 17, 364.
11. (b) Erfurth, A.; Schmauss, M. Fortschr. Neurol. Psychiatr. 1995, 63, 93.
12. (a) van Galen, P. J. M.; van Bergen, A. H.; Gallo-Rodriguez, C.; Melman, N.; Olah, M. E.; IJzerman, A. P.; Stiles, G. L.; Jacobson, K. A. Mol. Pharmacol. 1994, 45, 1101.
13. (b) Linden, J.; Taylor, H. E.; Robeva H. S.; Tucker, A. L.; Stehle, J. H.; Rivkees, S. A.; Fink, J. S.; Reppert, S. M. Mol. Pharmacol. 1993, 44, 524.
14. (c) Salvatore, C. A.; Jacobson, M. A.; Taylor, H. E.; Linden, J.; Johnson, R. G. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365.
15. May, J. M.; Martin, P. L.; Miller, J. R. Fed. Am. Soc. Exp. Biol. J. 1991, 5, 572.
16. Thompson, R. D.; Secunda, S.; Daly, J. W.; Olsson, R. A. J. Med. Chem. 1991, 34, 2877.
17. Martin, P. L.; Ueeda, M.; Olsson, R. A. J. Pharm. Exper. Ther. 1993, 265, 248.
18. Jacobson, K. A.; Siddiqi, S. M.; Olah, M. E.; Ji, X. D.; Melman, N.; Bellamkonda, K.; Meshulam, Y.; Stiles, G. L.; Kim, H. O. J. Med. Chem. 1995, 38, 1720.
19. Vittori, S.; Camaioni, E.; Di Francesco, E.; Volpini, R.; Klotz, K.-N.; Lohse, M. J. Cristalli, G. Drug Dev. Res. 1996, 37, 113.
20. Nair, V.; Richardson, S. G. J. Org. Chem. 1980, 45, 3969.
21. Kim, S.-H.; Rich, A. Proc. Natl. Acad. Sci. U.S.A. 1968, 60, 402.
22. Zemlicka, J. Nucleosides Nucleotides 1984, 3, 245.
23. Lohse, M. J. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992, 345, 444.
24. Lohse, M. J.; Klotz, K.-N.; Lindenborn-Fotinos, J.; Reddington, M.; Schwabe, U.; Olsson, R. A. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 336, 204.
25. Jarvis, M. F.; Schutz, R.; Hutchison, A. J.; Do, E.; Sills, M. A.; Williams, M. Mol. Pharmacol. 1994, 45, 978.
26. Olah, M. E.; Gallo-Rodriguez, C.; Jacobson, K. A.; Stiles, G. L. J. Pharm. Exper. Ther. 1993, 265, 248.
27. Klotz, K-N.; Cristalli, G.; Grifantini, M.; Vittori, S.; Lose, M. J. J. Biol. Chem. 1985, 260, 14659.
28. Cheng, Y.-C.; Prusoff, W. H. Biochem. Pharmacol. 1973, 22, 3099.
29. Ji, X.-d.; von Lubitz, D.; Olah, M. E., Stiles, G. L.; Jacobson, K. A. Drug Dev. Res. 1994, 33, 51.
30. Klotz, K.-N.; Heßling, J.; Hegler, J.; Owmanl, C.; Kull, B.; Fredholm, B. B.; Lohse, M. J. Naunyn-Schmiedeberg's Arch. Pharm. 1998, 357, 1.